Saibo Co., Ltd.
Saibo Co., Ltd. (3123) is a prominent player in the biotechnology and pharmaceuticals sector, specializing in the development and manufacturing of innovative medical solutions and health-related products. The company focuses on research and development of advanced therapeutics, particularly in areas such as oncology, immunology, and regenerative medicine. Saibo also engages in providing contract research and manufacturing services to other biotech firms, enhancing its portfolio with a diverse range of offerings aimed at improving patient outcomes.